KalVista Pharmaceuticals
KALV
KALV
73 hedge funds and large institutions have $244M invested in KalVista Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 28 increasing their positions, 14 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
2.98% more ownership
Funds ownership: 73.98% → 76.96% (+3%)
4% less funds holding
Funds holding: 76 → 73 (-3)
Holders
73
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$13.2M | |
| 2 | +$5.05M | |
| 3 | +$4.87M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$3.4M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$2.63M |
Top Sellers
| 1 | -$13.3M | |
| 2 | -$10.3M | |
| 3 | -$3.56M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.01M |
| 5 |
Neuberger Berman Group
New York
|
-$682K |